ProMIS Neurosciences, Inc.
PMN
$10.57
$0.080.76%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 116.62% | 282.14% | 438.18% | 157.29% | 94.36% |
| Gross Profit | -116.62% | -282.14% | -438.18% | -157.29% | -94.36% |
| SG&A Expenses | -16.30% | 4.39% | 31.90% | 28.52% | 1.71% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 79.46% | 164.96% | 275.31% | 102.90% | 54.92% |
| Operating Income | -79.46% | -164.96% | -275.31% | -102.90% | -54.92% |
| Income Before Tax | -4,381.15% | -224.84% | -285.60% | -102.14% | 93.35% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4,381.15% | -224.84% | -285.60% | -102.14% | 93.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4,381.15% | -224.84% | -285.60% | -102.14% | 93.35% |
| EBIT | -79.46% | -164.96% | -275.31% | -102.90% | -54.92% |
| EBITDA | -- | -- | -- | -- | -55.50% |
| EPS Basic | -2,321.40% | -176.75% | -118.75% | -13.30% | 96.26% |
| Normalized Basic EPS | -276.81% | -176.76% | -118.75% | -13.30% | 151.24% |
| EPS Diluted | -1,883.76% | -177.68% | -118.75% | -13.30% | 95.38% |
| Normalized Diluted EPS | -276.81% | -176.86% | -118.75% | -13.30% | 151.24% |
| Average Basic Shares Outstanding | 85.10% | 62.66% | 76.28% | 78.40% | 77.78% |
| Average Diluted Shares Outstanding | 85.10% | 62.42% | 76.28% | 78.40% | 77.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |